Home › Tumors and Pregnancy › NCT06022458
Prenatal Sonographic Prediction of Placental Histology and Function
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 to 60 · Women · Healthy volunteers welcome
Full eligibility criteria
Retrospective Phase Inclusion criteria: * Patients with delivery in NorthShore University HealthSystem, * Ultrasound available within 4 weeks of delivery with adequate placental images * Placental pathology available Exclusion criteria: * Multiple gestation Prospective Phase Inclusion criteria * Exposed: Patients with singleton gestation with fetal growth restriction at 20-28 weeks with a plan to deliver at NorthShore Highland Park Hospital Evanston Hospital. Patients must have a first-trimester ultrasound (\<14 weeks) to confirm pregnancy dating available in the electronic medical record. * Unexposed: Patients who present for routine ultrasound evaluation at 36-38 weeks with normal fetal growth with a plan to deliver at NorthShore Highland Park Hospital or NorthShore Evanston Hospital. Exclusion criteria: * Exposed: Multiple gestation, major fetal anomaly * Unexposed: Multiple gestation, history of chronic hypertension, gestational or pregestational diabetes, major fetal anomaly antiphospholipid syndrome, known thrombophilia
About the study
The purpose of this two-phase observational study is to investigate the use of ultrasonography to predict placental pathology at the time of delivery.
Sponsor: Endeavor Health · Participants: 320 · Started: May 28, 2024
Contact the study team
- Sunitha Suresh · Phone: 8475702860
- Camilla Lee · Phone: (847) 570-4729
Official record on ClinicalTrials.gov — NCT06022458
Locations in the U.S.
| Illinois | NorthShore University HealthSystem, Evanston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.